Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2019-12-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
首次公开发行前已发行股份上市流通提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on previously non-tradable shares (restricted shares) and their subsequent listing for trading. It includes specifics about the number of shares becoming tradable, shareholder commitments related to share lock-up and reduction, and the dates when shares will be freely tradable. The document references regulatory approvals and shareholder commitments but does not contain financial statements or earnings data. It is not a report like an Annual Report or Interim Report, nor is it a proxy or voting result announcement. It is a regulatory announcement about share listing and circulation status, specifically about the removal of share restrictions and related shareholder commitments. This fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2019-12-03 Chinese
公司章程（2019年11月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 西藏易明西雅医药科技股份有限公司, dated November 2019. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and other governance matters. The content is focused on the internal rules, structure, and governance practices of the company rather than financial results, meeting presentations, or announcements. There is no indication that this is an annual report, earnings release, or any other financial or regulatory filing. The document is a comprehensive governance document outlining the company's bylaws and internal governance framework. Therefore, it fits the category of Governance Information (CGR).
2019-11-25 Chinese
关于召开2019年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice for convening the 2019 third extraordinary general meeting of shareholders of a company, detailing the meeting time, location, voting methods, agenda items, and procedures for attendance and voting. It includes instructions for shareholders on how to participate in the meeting and vote, as well as an authorization proxy form for voting. There is no financial data, earnings information, or report content. The document is an announcement about the meeting itself, not the results or the report of the meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2019-11-25 Chinese
关于公司变更注册资本、经营范围并修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company about changes to its registered capital, business scope, and amendments to its Articles of Association (Company Charter). It details the approval of these changes by the board and mentions that the proposal will be submitted to a shareholders' meeting for approval. The document does not contain financial statements or detailed financial data, nor is it a report like an annual or interim report. It is a formal announcement of corporate governance changes related to capital and business scope, which fits best under the category of Share Issue/Capital Change (SHA) because it involves changes in registered capital and related corporate documents. The document length is 2612 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the classification is SHA with high confidence.
2019-11-25 Chinese
第二届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 12th meeting of the 2nd Board of Directors of the company. It details the meeting date, attendance, voting results, and references to related announcements for further details. The content focuses on board decisions such as changes in registered capital, business scope, and amendments to the company bylaws, as well as the calling of a shareholders' meeting. There is no financial data, audit information, or report publication mentioned. The document is clearly about board meeting resolutions and decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS. Therefore, the correct classification is MANG with high confidence.
2019-11-25 Chinese
关于2019年首期限制性股票授予完成的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the completion of the first grant of restricted stock under a 2019 stock incentive plan by the company 西藏易明西雅医药科技股份有限公司. It details the number of shares granted, the recipients, approval procedures, listing date, shareholding changes, and related financial and regulatory compliance information. The document is not a full financial report, earnings release, or management discussion, but rather a formal announcement of a capital change related to share issuance to employees and management. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length and content support a high confidence classification.
2019-11-10 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.